What’s Actually Compliant in AI for Life Sciences? A 2026 Reality Check Explore what AI compliance means in 2026 for life sciences. Learn key FDA, EU AI Act insights, validation tips, and how to scale AI responsibly. John Petrakis - December 19, 2025 Blogs Biotech, Medical Device, Pharma Information Technology, Quality Assurance, Regulatory
Modernizing TPRM for an AI-Driven Ecosystem: What Good Looks Like in 2026 Life sciences must modernize TPRM to safely scale AI and cloud tech. Discover 2026-ready risk strategies that enable innovation, compliance, and trust. Brian Rankin - December 18, 2025 Blogs Biotech, Medical Device, Pharma Clinical, Information Technology, Quality Assurance
USDM Life Sciences Summit 2026 Join the 2026 USDM Life Sciences Summit to explore AI, digital trust, automation, and compliant transformation. Innovation at the speed of change. Webinars Biotech, CMO, CRO, Medical Device, Pharma Clinical, Information Technology, Manufacturing, Quality Assurance, Regulatory, Research & Development, Safety
FDA AI Guidance 2025: What Life Sciences Must Do Now Explore the FDA’s evolving AI enforcement, new guidance, and what life-science organizations must do to stay compliant with AI in GxP environments. John Petrakis - November 17, 2025 Blogs Medical Device, Pharma Information Technology, Quality Assurance
How to Leverage USDM’s Vendor Audit of Oracle Supply Chain Management Cloud How to Leverage USDM’s Vendor Audit of Oracle Supply Chain Management Cloud John Danese - November 6, 2025 Blogs Biotech, CMO, CRO, Medical Device, Pharma Manufacturing
The Hidden Costs of Offshore IT Projects in Life Sciences: Why Local Expertise Matters Discover why offshore IT projects fail in life sciences and how USDM Life Sciences delivers local, compliant, and accountable project success. John Danese - October 6, 2025 Blogs Biotech, Medical Device, Pharma Information Technology, Quality Assurance
